Product liability law holds that a manufacturer may be held responsible when a product it designs, makes, or sells is unreasonably dangerous because of a design defect, a manufacturing defect, or inadequate warnings, and that defect causes injury. These rules come from state law and vary from state to state, but most states recognize some form of each of the three theories. Reusable medical scopes are products, and patients who develop serious infections after a procedure may have grounds for a product liability claim against the device maker.
Current Status of Olympus Endoscope Litigation (Updated September 2026)
As of September 2026, Olympus endoscope cases are not consolidated into a federal multidistrict litigation (MDL). The Judicial Panel on Multidistrict Litigation's September 1, 2026 report lists 166 active MDLs, and none involves Olympus scopes. Claims are generally pursued as individual lawsuits, meaning each case is built around one patient's procedure, infection, and losses.
Several federal actions form part of the public record behind these claims:
- 2018 guilty plea: Olympus Medical Systems Corporation and a former senior executive pleaded guilty in federal court to failing to file FDA-required reports of infections connected to its duodenoscopes while continuing to sell them. According to the Department of Justice, the company agreed to pay $85 million.
- 2025 FDA import alerts: In June 2025, the FDA issued import alerts blocking certain Olympus ureterorenoscopes, bronchoscopes, laparoscopes, and automated endoscope reprocessors from entering the U.S. due to outstanding quality system violations.
Because this litigation is still developing, the landscape may change. An MDL could be requested in the future, and new regulatory actions may affect individual claims. Correa & Martinez monitors these developments and will update this page as the status changes.




